Log on / register
Feedback | Support | My details

Comments

A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment

Anthony Gonçalves* email, Séverine Esteyries* email, Brynn Taylor-Smedra email, Arnaud Lagarde email, Mounay Ayadi email, Geneviève Monges email, François Bertucci email, Benjamin Esterni email, Jean-Robert Delpero email, Olivier Turrini email, Bernard Lelong email, Patrice Viens email, Jean-Paul Borg email, Daniel Birnbaum email, Sylviane Olschwang email and Frédéric Viret email

BMC Cancer 2008, 8:169doi:10.1186/1471-2407-8-169

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.